Anti-IFN gamma Receptor beta/AF-1 antibody [EPR8813],Abcam,AB171081
Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .
Host
Rabbit
Reactivity
Human
Application
WB
Platform ID
BAB972789832
Abcam
Contact
Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215
Email:
Product Specifications
Scientific Background
Specifications
NameAnti-IFN gamma Receptor beta/AF-1 antibody [EPR8813]
Cat. No.AB171081
HostRabbit
IsotypeIgG
ReactivityHuman
ApplicationWB
ClonalityMonoclonal
Clone NumberEPR8813
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: BSA, Glycerol (glycerin, glycerine)
Storage-20°C
Regulatory StatusResearch Use Only
Scientific Background
Target data Associates with IFNGR1 to form a receptor for the cytokine interferon gamma (IFNG) (PubMed : 7615558, PubMed : 7673114, PubMed : 8124716). Ligand binding stimulates activation of the JAK/STAT signaling pathway (PubMed : 15356148, PubMed : 7673114, PubMed : 8124716). Required for signal transduction in contrast to other receptor subunit responsible for ligand binding (PubMed : 7673114). See full target information IFNGR2
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
- Products>Primary Antibodies>Recombinant Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.